Ets2 and Mesp1 generate cardiac progenitors from fibroblasts
MetadataShow full item record
A method for modulating cell differentiation capabilities using heterologous gene expression. Some embodiments of the invention relate to a method for inducing a cardiac progenitor cell by delivering a reprogramming factor to the cell, wherein the reprogramming factor comprises ETS2 or a combination of ETS2 and Mesp1.
Schwartz, Robert J.; Potaman, Vladimir N.; Islas, Jose Francisco (2015). Ets2 and Mesp1 generate cardiac progenitors from fibroblasts. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from